| scholarly article | Q13442814 |
| P2093 | author name string | Samuel J Hassenbusch | |
| Victor A Levin | |||
| Dennis Pietronigro | |||
| Emilio M Nardone | |||
| Norman Leeds | |||
| P2860 | cites work | Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse | Q30647642 |
| Convection-enhanced delivery of macromolecules in the brain | Q35091232 | ||
| A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse | Q36621800 | ||
| Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group | Q38573324 | ||
| Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials | Q40789890 | ||
| DTI-015 produces cures in T9 gliosarcoma | Q41562477 | ||
| Intracarotid BCNU leukoencephalopathy | Q42226644 | ||
| High-flow microinfusion: tissue penetration and pharmacodynamics | Q48194879 | ||
| Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas | Q48517573 | ||
| Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors | Q48587395 | ||
| Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging | Q48619629 | ||
| A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma | Q55483561 | ||
| Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion | Q71694555 | ||
| P433 | issue | 1 | |
| P921 | main subject | phase I clinical trial | Q5452194 |
| phase II clinical trial | Q42824440 | ||
| P304 | page(s) | 9-16 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Neoplasia | Q2962042 |
| P1476 | title | Stereotactic injection of DTI-015 into recurrent malignant gliomas: phase I/II trial | |
| P478 | volume | 5 |
| Q28389391 | A review of the past, present, and future directions of neoplasia |
| Q38867048 | Blood-brain barrier, cytotoxic chemotherapies and glioblastoma |
| Q53146125 | CT-guided percutaneous chemoablation using an ethanol-ethiodol-doxorubicin emulsion for the treatment of metastatic lymph node carcinoma: a comparative study. |
| Q28389985 | Coming of Age in the Life of |
| Q50090665 | Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models |
| Q36478643 | Convection-enhanced and local delivery of targeted cytotoxins in the treatment of malignant gliomas |
| Q39922287 | DNA alkylation products formed by 1-(2-chloroethyl)-1-nitrosourea as molecular dosimeters of therapeutic response |
| Q41562477 | DTI-015 produces cures in T9 gliosarcoma |
| Q54970083 | Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme. |
| Q30992978 | Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor--a pharmacokinetic study |
| Q42914128 | Levels and distribution of BCNU in GBM tumors following intratumoral injection of DTI-015 (BCNU-ethanol). |
| Q47987226 | Mathematical Modelling of Convection Enhanced Delivery of Carmustine and Paclitaxel for Brain Tumour Therapy |
| Q35939662 | Neurosurgical delivery of chemotherapeutics, targeted toxins, genetic and viral therapies in neuro-oncology |
| Q33912220 | Percutaneous Fine-Needle 5% Ethanol-Cisplatin Intratumoral Injection Combined with Second-Line Chemotherapy Improves On the Standard of Care in Patients with Platinum-Pretreated Stage IV Non-Small Cell Lung Cancer |
| Q43197979 | Phase II trial of intratumoral BCNU injection and radiotherapy on untreated adult malignant glioma |
| Q36750162 | Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). |
| Q35939646 | The changing role of stereotaxis in surgical neuro-oncology |
Search more.